Aprecia Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Lucknow, Uttar Pradesh, India, established in 2017.
2017 Lucknow, Uttar Pradesh, India Active
Last Updated:
Access Report
About Aprecia Pharmaceuticals Private Limited

Aprecia Pharmaceuticals Private Limited, a active private limited company, was established on 16 May 2017 in Lucknow, Uttar Pradesh, India. Engaging in other services within the business services sector, it holds CIN: U74999UP2017PTC093123. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Formerly known as Aminabad Surgical Private Limited. It upholds a compliant status. Its leadership includes Muneeb Alvi (Director), Mohammad Meesam Khan (Additional Director). Past directors included Syed Kamran Ahsan, Mohammad Asif Khan, Mohammad Yasir Arafat. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 005, Grandeur Apartment Building No.6 Dalibagh, Lucknow, Uttar Pradesh, 226001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999UP2017PTC093123

  • Registration Number

    093123

  • Incorporation Date

    16 May 2017

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -13.46%
  • Profit Growth **** 4.89%
  • Ebitda **** -150.47%
  • Net Worth 221.84%
  • Total Assets **** 18.65%
Company report

Aprecia Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aprecia Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Aprecia Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Muneeb Alvi Director 16 May 2017 Current
Mohammad Meesam Khan Additional Director 15 Dec 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Jan 2024 Past
Pramod Abcsdd Director 08 Jan 2024 Past
Pramod Abcsdd Director 25 Jun 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aprecia Pharmaceuticals.

Aprecia Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 13.46% decrease. The company also saw a slight improvement in profitability, with a 4.89% increase in profit. The company's net worth Soared by an impressive increase of 221.84%.

Aprecia Pharmaceuticals revenue growth over time
Aprecia Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -13.46%
*******
*******
*******
*******
Revenue from Operations
*******
 -13.47%
*******
*******
*******
*******
Total Assets
*******
 18.65%
*******
*******
*******
*******
Profit or Loss
*******
 4.89%
*******
*******
*******
*******
Net Worth
*******
 221.84%
*******
*******
*******
*******
EBITDA
*******
 -150.47%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aprecia Pharmaceuticals?

Unlock access to Aprecia Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aprecia Pharmaceuticals?

Unlock and access historical data on people associated with Aprecia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aprecia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aprecia Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aprecia Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Aprecia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Aprecia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was documented.

  • Director Appointment

    Progress on Mohammad Meesam Khan was appointed as a Additional Director was appointed as a Additional Director on 15 Dec 2023 & has been associated with this company since 2 years 2 months . was documented.

  • Director Appointment

    The activity Muneeb Alvi was appointed as a Director was appointed as a Director on 16 May 2017 & has been associated with this company since 8 years 9 months . was completed.

  • Company Incorporation

    Aprecia Pharmaceuticals Private Limited was registered on 16 May 2017 with Roc Kanpur & aged 8 years 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aprecia Pharmaceuticals Private Limited?

The CIN of Aprecia Pharmaceuticals Private Limited is U74999UP2017PTC093123.

Where is Aprecia Pharmaceuticals Private Limited headquartered?

Aprecia Pharmaceuticals Private Limited is headquartered at 005, Grandeur Apartment Building No.6 Dalibagh, Lucknow, Uttar Pradesh, 226001.

When was Aprecia Pharmaceuticals Private Limited incorporated?

Aprecia Pharmaceuticals Private Limited was incorporated on 16 May 2017.

Who are the current directors of Aprecia Pharmaceuticals Private Limited?

The current directors of Aprecia Pharmaceuticals Private Limited are

What is the primary industry of Aprecia Pharmaceuticals Private Limited?

The primary industry of Aprecia Pharmaceuticals Private Limited is Business Services.

Is Aprecia Pharmaceuticals Private Limited a listed company?

Aprecia Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Aprecia Pharmaceuticals Private Limited?

The authorized capital of Aprecia Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Aprecia Pharmaceuticals Private Limited?

The compliance status of Aprecia Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available